simvastatin has been researched along with Hyperandrogenism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banaszewska, B; Duleba, AJ; Pawelczyk, L; Spaczynski, RZ | 2 |
Cengiz, SD; Dünder, I; Kaya, C; Pabuccu, R | 1 |
Hart, RJ; Hunter, T; Raval, AD; Stuckey, B | 1 |
1 review(s) available for simvastatin and Hyperandrogenism
Article | Year |
---|---|
Statins for women with polycystic ovary syndrome not actively trying to conceive.
Topics: Adult; Atorvastatin; Female; Heptanoic Acids; Hirsutism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hypoglycemic Agents; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Young Adult | 2011 |
3 trial(s) available for simvastatin and Hyperandrogenism
Article | Year |
---|---|
Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
Topics: Adult; Cardiovascular Diseases; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hypoglycemic Agents; Lipids; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Simvastatin; Testosterone | 2009 |
Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
Topics: Adult; Atorvastatin; C-Reactive Protein; Fasting; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Inflammation; Insulin; Insulin Resistance; Luteinizing Hormone; Oxidative Stress; Polycystic Ovary Syndrome; Prospective Studies; Pyrroles; Simvastatin; Testosterone; Young Adult | 2010 |
Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.
Topics: Adult; C-Reactive Protein; Drug Therapy, Combination; Female; Hirsutism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hypoglycemic Agents; Lipoproteins, LDL; Metformin; Polycystic Ovary Syndrome; Simvastatin; Treatment Outcome | 2011 |